Rethinking the value of survival: clinical trials should measure patient preferences for survival on entry to trials
Doctor J, Huesch M, Meeker D. Rethinking the value of survival: clinical trials should measure patient preferences for survival on entry to trials. Journal Of Clinical Epidemiology 2016, 77: 137-138. PMID: 27164276, DOI: 10.1016/j.jclinepi.2016.03.030.Peer-Reviewed Original Research